Open access · OA
via OpenAlex
Relief with Rapamycin: mTOR Inhibition Protects against Radiation-Induced Mucositis
Cell stem cell · 2012 · ▲ 11 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.stem.2012.08.003
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Finkel, T. (2012). Relief with Rapamycin: mTOR Inhibition Protects against Radiation-Induced Mucositis. <em>Cell stem cell</em>. https://doi.org/10.1016/j.stem.2012.08.003
Vancouver
Finkel T. Relief with Rapamycin: mTOR Inhibition Protects against Radiation-Induced Mucositis. Cell stem cell. 2012. doi:10.1016/j.stem.2012.08.003.
BibTeX
@article{toren2012Relief,
title = {Relief with Rapamycin: mTOR Inhibition Protects against Radiation-Induced Mucositis},
author = {Toren Finkel},
journal = {Cell stem cell},
year = {2012},
doi = {10.1016/j.stem.2012.08.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience 2012
Citation only
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
Nature Communications 2019
Open access · CC-BY
A novel rapamycin analog is highly selective for mTORC1 in vivo
Cold Spring Harbor Perspectives in Medicine 2016
Open access · OA
Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
Pharmacological Reviews 2018
Open access · OA
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
International Journal of Molecular Sciences 2021
Open access · CC-BY
The Role of mTOR Signaling as a Therapeutic Target in Cancer
Aging Cell 2021
Open access · CC-BY